Evidence map›Paper›PMID 30987106›Full record

ArticleInternational journal of molecular sciences2019

Conditioned Medium from Human Mesenchymal Stromal Cells: Towards the Clinical Translation.

Georgy Sagaradze, Olga Grigorieva, Peter Nimiritsky, Nataliya Basalova, Natalia Kalinina, Zhanna Akopyan, Anastasia Efimenko

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Zinc sulfate modulates the C3H10T1/2 mesenchymal stem cell line secretome and NFκB signaling during inflammation to influence selected immune cell responses.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Georgy SagaradzeInstitute for Regenerative Medicine, Medical Research and Education Center, Lomonosov Moscow State University, 27-10, Lomonosovsky av., Moscow 119191, Russia. georgy.sagaradze@gmail.com.ORCID 0000-0003-2551-5118
Olga GrigorievaInstitute for Regenerative Medicine, Medical Research and Education Center, Lomonosov Moscow State University, 27-10, Lomonosovsky av., Moscow 119191, Russia. go.grigorievaolga@gmail.com.
Peter NimiritskyInstitute for Regenerative Medicine, Medical Research and Education Center, Lomonosov Moscow State University, 27-10, Lomonosovsky av., Moscow 119191, Russia. nimiritsky@gmail.com.ORCID 0000-0003-2263-2239
Nataliya BasalovaInstitute for Regenerative Medicine, Medical Research and Education Center, Lomonosov Moscow State University, 27-10, Lomonosovsky av., Moscow 119191, Russia. natalia_ba@mail.ru.
Natalia KalininaFaculty of Medicine, Lomonosov Moscow State University, 27-1, Lomonosovsky av., Moscow 119192, Russia. n_i_kalinina@mail.ru.ORCID 0000-0003-3497-9619
Zhanna AkopyanInstitute for Regenerative Medicine, Medical Research and Education Center, Lomonosov Moscow State University, 27-10, Lomonosovsky av., Moscow 119191, Russia. zhanna.fbm@gmail.com.
Anastasia EfimenkoInstitute for Regenerative Medicine, Medical Research and Education Center, Lomonosov Moscow State University, 27-10, Lomonosovsky av., Moscow 119191, Russia. efimenkoan@gmail.com.ORCID 0000-0002-0696-1369

Funding

Moscow State University Program of Development -Russian Foundation for Basic Research №18-315-00403Russian Science Foundation № 14-50-00029
6 · The paper itself

Abstract

Mesenchymal stem/stromal cells (MSC) remain a promising tool for regenerative medicine as the efficacy of MSC-based cell therapy has been demonstrated for a broad spectrum of indications. Their therapeutic potency is mainly associated with their ability to secrete multiple factors critical for tissue regeneration. Due to comparable effects along with superior safety MSC conditioned medium (MSC-CM) containing a complex of MSC-secreted products is considered a reasonable alternative to cell therapy. However, the lack of standards regulating bioprocessing, use of proper auxiliary materials, and quality control complicates the development of MSC secretome-based therapeutics. In this study, we suggested several approaches addressing these issues. We manufactured 36 MSC-CM samples based on different xeno-free serum-free chemically defined media (DMEM-LG or MSC NutriStem

Indexed as

Translational Research, BiomedicalCell MovementCell SurvivalCulture Media, ConditionedDermisEndothelial CellsFibroblastsHumansIntercellular Signaling Peptides and ProteinsMesenchymal Stem CellsModels, BiologicalRegression AnalysisCulture Media, ConditionedIntercellular Signaling Peptides and Proteinsconditioned mediumgrowth factorsmanufacturingmesenchymal stem/stromal cellsquality controlregenerative medicineregression analysissecretome

Identifiers

PMID30987106
PMCPMC6479925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.